An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho was quoted in an Inside Health Policy article this week discussing his concerns on the Department of Health and Human Service’s (HHS) plans to build a CER inventory before the creation of the Patient Centered Outcomes and Research Institute, an independent board that will facilitate CER research.
The latest addition of Congressional Quarterly (CQ) features an article on comparative effectiveness research (CER) in which Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho weighs in on the issue.
Partnership to Improve Patient Care Chairman Tony Coelho recently sent a letter to Sherry Glied, the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services (HHS), recommending that the Agency work closely with the Patient Centered Outcomes and Research Institute when building its planned nationwide CER database.
Speaking at the Partnership to Improve Patient Care's (PIPC) forum on CER July 22, Sen. Max Baucus (D-MT) highlighted the promise of the health reform law in delivering patient-centered CER and pledged "diligent oversight" to ensure it fulfills this promise in implementation.
Partnership to Improve Patient Care (PIPC) chairman, Tony Coelho, recently delivered a speech on patient centered comparative effectiveness research (CER) in front of fifty specialty doctors from around the country, among others, at the Alliance for Specialty Medicine’s (ASM) “Capitol Hill Advocacy Conference.” The conference took place just a day before the specialty doctors met w
Below: PIPC Chairman Tony Coelho's recent speech on patient centered CER. The speech was delivered on Tuesday, June 22, 2010 at the Alliance for Specialty Medicine's “Capitol Hill Advocacy Conference,” in Washington, D.C.
A new Health Affairs article concludes, based on focus groups and interviews, that "consumers will revolt if evidence-based efforts are perceived as rationing or as a way to deny them needed treatment."
You don't need to look any further than public reaction to the U.S. Preventive Service Task Force's updated recommendations on mammography screening to see the proof of this.
How should policy-makers react? Should they conclude that consumers, and even more so, patients, cannot be relied on to make evidence-based decisions, and therefore these decisions need to be made for them? Or should they conclude that evidence-based models of medical care and health delivery need to be carefully constructed so they have the trust and support of patients and consumers?
With enactment of the Patient Protection and Affordable Care Act, the patient and provider communities now for the first time have a blueprint for patient-centered comparative effectiveness research written into law.
In a recent press release, PIPC outlined the most important CER provisions in the bill.
“Congress worked hard to pass health care reform that included patient-centered CER. The bill will result in the creation of the Patient-Cent
A recent Wall Street Journal article about the use of stent procedures in the medical community and the reaction to it by blogger Burt Cohen, offers another illustration of the complexities of comparative research, and again shows why results should be used to inform doctors and patients, but not to impose broad “one size fits all” prescriptions that do not reflect the complexities of the science or the differences in individual patients.
Tomorrow PIPC Chairman Tony Coelho will participate in a panel discussion on comparative effectiveness research (CER) here in Washington, DC. With Congress back in session and healthcare reform taking center stage, PIPC is continuing to engage Members of Congress about the importance of patient-centered CER.